<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02853383</url>
  </required_header>
  <id_info>
    <org_study_id>RRS-001</org_study_id>
    <nct_id>NCT02853383</nct_id>
  </id_info>
  <brief_title>Registry of COPD Patients From Outpatient Polyclinic Healthcare Institutions of the Russian Federation in Moscow</brief_title>
  <official_title>Registry of COPD Patients Who Undergo Outpatient Treatment or Are Under Surveillance at Outpatient Polyclinic Healthcare Institutions of the Russian Federation in Moscow</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Interregional Public Organization, Russian Respiratory Society</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Interregional Public Organization, Russian Respiratory Society</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine COPD prevalence among patients registered in the
      healthcare system of Moscow (under outpatient surveillance at polyclinic institutions of
      Moscow).

      To describe the clinical profile of COPD patient who is under outpatient surveillance at
      polyclinic institutions of Moscow (including demographic data (age, gender, ethnicity,
      occupation), smoking status, disease duration, disease severity grade, distribution by
      disease phenotype, disease exacerbation rate in the setting of real-life clinical practice).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The registry of COPD patients in fact represents two parts of a non-interventional
      multicenter descriptive study: one of these parts is a retrospective study including all COPD
      patients, and the other part is an observational prospective cohort study of COPD patients
      included into the registry and newly diagnosed under outpatient surveillance at the selected
      polyclinic institutions of Moscow with annual retrospective entry of data.

      Monitoring will be performed for 3 years with regular (yearly) entry of data concerning
      patients with diagnosed COPD; it will include all patients with registered diagnoses J40 -
      J44 according to ICD-10 with spirometry results confirming COPD diagnosis, who are at the
      study start under outpatient surveillance, and also newly registered patients diagnosed with
      COPD (ICD-10 J40 - J44, as confirmed by spirometry results) during the conduction of the
      registry program at the selected polyclinic institutions of Moscow (according to ICD: J40 -
      Bronchitis, not specified as acute or chronic, J41 - Simple and mucopurulent chronic
      bronchitis, J41.0 - Simple chronic bronchitis, J41.8 - Mixed simple and mucopurulent chronic
      bronchitis, J 42 - Unspecified chronic bronchitis, J 43 - Emphysema, J 44 - Other chronic
      obstructive pulmonary disease) based on regular (yearly) retrospective analysis of patient
      records with data entry into a consolidated database.

      The present observational multicenter descriptive study will be conducted in the setting of
      routine clinical practice of outpatient polyclinic institutions. There is no hypothesis to be
      tested in this study.

      The study will be conducted in outpatient polyclinic institutions of the primary medical care
      system of Moscow. Pulmonologists of the primary medical care system will be engaged as
      investigators. These are the physicians, whom the patients with tentative COPD diagnosis are
      referred to in the Russian Federation and who within the scope of their responsibilities have
      access to source medical records and who evaluate the quality of diagnosis and extent of
      treatment prescribed to COPD patients.

      The present study is observational therefore it does not require a treatment regimen or
      directions for patient management. The patients receive medical care in line with routine
      practice for treatment of this disease in the Russian Federation. Patient participation in
      the study should not in any way affect the principles and extent of treatment received by the
      patient according to routine clinical practice.

      Physicians-investigators will enter into the study the information (data) concerning COPD
      patients, both those already registered at the selected medical treatment and preventive care
      institution, and newly registered patients as they seek attention at the outpatient
      polyclinic institutions.

      Patient data will be entered into the registry de-identified. The patients will be identified
      by their screening number and initials. Then the Physician-investigator will evaluate patient
      compliance with inclusion criteria. The study will enrol patients meeting all the inclusion
      criteria and not having any of the exclusion criteria.

      Only the physician who enters patient data into the regional COPD registry possesses patient
      contact information, and henceforth only this physician will enter de-identified patient data
      according to study design. This physician does not influence the choice of examination
      extent, treatment strategy and medication.

      Primarily epidemiological methods will be used for presentation of the study results.
      Descriptive analysis approach will be applied for analysis of the study objectives.
      Descriptive statistics will be used for analysis of the study population, baseline and
      clinical data.

      Descriptive statistics will include frequency tables (n, mean, median, standard deviation,
      minimum and maximum for continuous variables; n, frequency and percentage for categorical
      variables). Percentages will be evaluated together with 95% confidence intervals (in
      appropriate cases).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>COPD prevalence among patients registered in the healthcare system of Moscow (under outpatient surveillance at polyclinic institutions of Moscow).</measure>
    <time_frame>3 years</time_frame>
    <description>COPD prevalence among patients registered in the healthcare system of Moscow (under outpatient surveillance at polyclinic institutions of Moscow).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To describe the clinical profile of COPD patient in Moscow (including demographic data (age, gender, ethnicity, occupation), smoking status, disease duration, disease severity grade</measure>
    <time_frame>3 years</time_frame>
    <description>To describe the clinical profile of COPD patient who is under outpatient surveillance at polyclinic institutions of Moscow (including demographic data (age, gender, ethnicity, occupation), smoking status, disease duration, disease severity grade, distribution by disease phenotype, disease exacerbation rate in the setting of real-life clinical practice).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Characterize percentage (%) of COPD patients who seek attention from primary medical care physicians by severity of airway obstruction according to criteria described in Federal clinical guidelines</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterize percentage (%) of COPD patients who seek attention from primary medical care physicians by reversibility of airway obstruction according to criteria described in Federal clinical guidelines</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Monitoring of decrease in lung function (according to spirometry results).</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine prevalence of chronic bronchitis phenotype among outpatients</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine prevalence of the emphysema phenotype among outpatients</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine prevalence of the mixed phenotype among outpatients</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine prevalence of the frequent exacerbator phenotype among outpatients</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine prevalence of the Asthma+COPD phenotype among outpatients</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine the percentage of patients with eosinophilic inflammation according to haematology results</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe treatment regimens prescribed to COPD patients depending on disease severity grade in the setting of real-life clinical practice</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To establish the percentage of medical prescriptions for treatment of COPD patients which comply with current Federal clinical guidelines for diagnosis and treatment of chronic obstructive pulmonary disease.</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To establish prevalence of comorbidities in COPD patients.</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To establish pattern of comorbidities in COPD patients.</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To evaluate the disease burden based on the collected data concerning the duration of temporary disability of patients under outpatient surveillance</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To evaluate the disease burden based on the collected data concerning the number of hospitalizations due to COPD exacerbations</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To evaluate the disease burden based on the collected data concerning number of outpatient visits concerning COPD patients under outpatient surveillance</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">4050</enrollment>
  <condition>Pulmonary Disease, Chronic Obstructive</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Randomly selected polyclinic institutions of Moscow will take part in the study and enrol
        into the registry 4050 patients for representativeness of sample for analysis of COPD
        prevalence in Moscow.

        The patient population includes male and female patients over 40 years of age, smokers or
        ex-smokers, under outpatient surveillance at polyclinic institutions of Moscow with
        diagnosis codes according to ICD J40 - J44 and diagnosed COPD, as confirmed by spirometry
        results
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  smokers or ex-smokers, with previously diagnosed COPD

          -  COPD diagnosis corresponding to ICD codes J40 - J44 (J40 - Bronchitis, not specified
             as acute or chronic, J41 - Simple and mucopurulent chronic bronchitis, J41.0 - Simple
             chronic bronchitis, J41.8 - Mixed simple and mucopurulent chronic bronchitis, J 42 -
             Unspecified chronic bronchitis, J 43 - Emphysema, J 44 - Other chronic obstructive
             pulmonary disease

          -  COPD diagnosis confirmed by spirometry results (spirometry is performed as normal with
             bronchodilator testing using salbutamol 400 Âµg, post-BD FEV1\ FVC &lt; 0.7)

        Exclusion Criteria:

          -  Tuberculosis

          -  Sarcoidosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrey S Belevskiy, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Interregional Public Organization &quot;Russian Respiratory Society'</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Olga N Brodskaya, M.D., Ph.D.</last_name>
    <phone>+79166145695</phone>
    <email>rropulmo@mail.ru</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Natalia U Kravchenko, M.D.</last_name>
    <phone>+79161183219</phone>
    <email>pulmokongress@mail.ru</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Russian respiratory Society</name>
      <address>
        <city>Moscow</city>
        <zip>105077</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olga N Brodskaya, M.D., Ph.D</last_name>
      <phone>+79166145696</phone>
      <email>rropulmo@mail.ru</email>
    </contact>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 14, 2016</study_first_submitted>
  <study_first_submitted_qc>July 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 2, 2016</study_first_posted>
  <last_update_submitted>December 26, 2016</last_update_submitted>
  <last_update_submitted_qc>December 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic Obstructive Pulmonary Diseases, COPD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

